0001427920-20-000001.txt : 20200108
0001427920-20-000001.hdr.sgml : 20200108
20200108100320
ACCESSION NUMBER: 0001427920-20-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191010
FILED AS OF DATE: 20200108
DATE AS OF CHANGE: 20200108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Neff Jean
CENTRAL INDEX KEY: 0001427920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28666
FILM NUMBER: 20514682
MAIL ADDRESS:
STREET 1: C/O ABMC
STREET 2: 122 SMITH ROAD
CITY: KINDERHOOK
STATE: NY
ZIP: 12106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMERICAN BIO MEDICA CORP
CENTRAL INDEX KEY: 0000896747
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141702188
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 122 SMITH ROAD
CITY: KINDERHOOK
STATE: NY
ZIP: 12106
BUSINESS PHONE: 5187588158
MAIL ADDRESS:
STREET 1: 122 SMITH ROAD
CITY: KINDERHOOK
STATE: NY
ZIP: 12106
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-10-10
0
0000896747
AMERICAN BIO MEDICA CORP
abmc
0001427920
Neff Jean
C/O ABMC
122 SMITH ROAD
KINDERHOOK
NY
12106
1
0
0
0
Common Shares
2019-10-10
4
A
0
23014
0.09
A
23014
D
23,014 shares were issued to Neff (representing a value of significantly less than $10,000) as compensation for her attendance at a meeting of the Company's Board of Directors held in October 2019. This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicated in the Company's Proxy Statement filed with the Commission on April 20, 2018).
The volume weighted average price of the Company's common shares for the 10 days preceding the issuance was $0.0869.
Jean Neff
2020-01-08